OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on tough ovarian cancer
Disease control Recruiting nowThis study is testing whether combining the immunotherapy drug dostarlimab with an experimental drug called LB-100 can help control a specific, hard-to-treat type of ovarian cancer that has come back. It is for adults aged 18-75 whose cancer has returned after at least one prior …
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Virus therapy trial offers new hope for tough ovarian cancers
Disease control Recruiting nowThis study is testing if a modified virus called Olvi-Vec, given directly into the abdomen, can help chemotherapy work better for women with ovarian cancer that has stopped responding to standard platinum drugs. Participants will be randomly assigned to receive either the virus f…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC